Benzinga | Jul 29, 2021 04:11PM EDT

Vertex Pharmaceuticals Q2 EPS $3.11 Beats $2.28 Estimate, Sales $1.79B Beat $1.72B Estimate

Vertex Pharmaceuticals (NASDAQ:VRTX) reported quarterly earnings of $3.11 per share which beat the analyst consensus estimate of $2.28 by 36.4 percent. This is a 19.16 percent increase over earnings of $2.61 per share from the same period last year. The company reported quarterly sales of $1.79 billion which beat the analyst consensus estimate of $1.72 billion by 4.07 percent. This is a 17.45 percent increase over sales of $1.52 billion the same period last year.